+ND Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Inscriptainscripta.comSeries B · Feb 2017 · $23M
BiotechBoulder, US
Michael Graige(Executive Officer)Ron McGrath(Executive Officer)Sri Kosaraju(Executive Officer, Director)Dianna L. DeVore(Executive Officer)
BoardRoger Wyse(Director)inBryan Roberts(Director)in
Co-investorsForesite CapitaliGlobe PartnersKorysOak HC/FTOMX VenturesPaladin Capital Group+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.